Hermetica Superfood Encyclopedia
The Short Answer
Fireweed's primary bioactive compounds—the ellagitannin oenothein B, quercetin glucuronides, kaempferol glycosides, and chlorogenic acid derivatives—exert antioxidant, anti-inflammatory, and antiproliferative effects through modulation of oxidative stress pathways, inhibition of inflammatory mediators, and suppression of cancer cell DNA synthesis. In vitro, aqueous leaf extracts at 250 µg/mL reduced HT-29 human colon cancer cell proliferation to approximately 27% of control values over 60 hours, and oenothein B content in raw material ranges from 2–4.5% depending on geographic origin and harvest timing.
CategoryHerb
GroupEuropean
Evidence LevelPreliminary
Primary Keywordfireweed benefits
Fireweed — botanical close-up
Health Benefits
**Prostate Health Support**
Oenothein B and associated ellagitannins have been studied in the context of benign prostatic hyperplasia and prostate cell proliferation; Scandinavian herbal traditions specifically employ fireweed infusions as a prostate tonic, and these compounds are hypothesized to modulate aromatase and 5-alpha-reductase activity, though clinical verification in humans is pending.
**Antiproliferative Activity (In Vitro)**
Aqueous extracts at 250 µg/mL suppressed HT-29 colon carcinoma proliferation by approximately 73% relative to control over 60 hours, with quercetin and kaempferol glycosides identified as key contributors to dose- and time-dependent cytotoxicity via inhibition of DNA synthesis.
**Anti-Inflammatory Effects**
Quercetin derivatives and kaempferol glucosides downregulate pro-inflammatory signaling pathways including NF-κB and COX-2 expression, reducing biosynthesis of inflammatory eicosanoids; these actions underpin fireweed's traditional use for gastrointestinal inflammation and mucosal irritation.
**Antioxidant Protection**
Total polyphenol content in dried organic fireweed leaves reaches 4,189.80 mg/100 g dry matter, with ellagic acid comprising 2,790.44 mg/100 g, conferring substantial free radical scavenging capacity that protects cellular membranes and DNA from oxidative damage.
**Gut Microbiome Selectivity**
Post-digestion aqueous extracts retain antimicrobial activity against pathogenic Escherichia coli while leaving beneficial Lactobacillus and Bifidobacterium species unaffected, suggesting a prebiotic-adjacent role in supporting gut microbial balance.
**Gastrointestinal Mucosal Support**
Phenolic acids including neochlorogenic acid (37.3 µg/mL in infusions post-digestion) and chlorogenic acid (20.8 µg/mL) contribute to mucosal protective effects through antioxidant and mild astringent actions, consistent with traditional use for diarrhea, gastritis, and intestinal inflammation.
**Neuroprotective Potential (Preclinical)**
Extracts have demonstrated inhibition of DNA synthesis in astrocytoma cell lines in vitro, with quercetin's known capacity to cross the blood-brain barrier and modulate neuroinflammation suggesting potential neuroprotective applications that remain entirely unvalidated in human studies.
Origin & History
Natural habitat
Epilobium angustifolium is native to the temperate and boreal regions of the Northern Hemisphere, thriving across Scandinavia, northern Europe, Siberia, and North America, particularly in disturbed soils, forest clearings, and post-fire landscapes from which it derives its common name. It grows best in well-drained, nutrient-rich soils at altitudes ranging from lowland meadows to subalpine zones, and is a pioneering species that rapidly colonizes burned or cleared land. Commercial cultivation is practiced in Scandinavia and Eastern Europe, with organic and biodynamic growing conditions documented to maximize total polyphenol content, while hydroponic production methods have also been explored to enhance biomass yield and phytochemical density.
“Fireweed has been used for centuries across Circumpolar and Northern European cultures, with its most documented traditional application as 'Ivan Chai' in Russian herbal medicine, where fermented fireweed leaves were brewed as a caffeine-free tea substitute used for calming, anti-inflammatory, and digestive purposes, consumed so widely in pre-Revolutionary Russia that it was a significant export commodity to Europe. In Scandinavian folk medicine, particularly in Norway, Sweden, and Finland, decoctions and infusions of Epilobium species have been specifically employed as remedies for benign prostatic hyperplasia and urinary complaints in older men, a use that attracted modern phytochemical investigation into oenothein B as the putative active constituent. Indigenous North American peoples including various First Nations groups used the plant as a food source—young shoots consumed raw or cooked—and applied poultices of the leaves to skin wounds and burns. The plant's association with post-disturbance landscapes, particularly its rapid proliferation following the volcanic eruption of Mount St. Helens in 1980 and across post-fire boreal forests, has imbued it with cultural symbolism of resilience and regeneration in both European and North American contexts.”Traditional Medicine
Scientific Research
The evidence base for fireweed is currently limited to in vitro cell culture studies and phytochemical characterization analyses; no human randomized controlled trials, observational cohort studies, or even formal animal pharmacokinetic studies with defined endpoints have been published in the indexed literature as of available sources. In vitro studies have quantified antiproliferative effects on HT-29 human colon adenocarcinoma cells and astrocytoma cell lines, demonstrating dose-dependent reductions in proliferation (up to ~73% inhibition at 250 µg/mL) and impedance changes over 60-hour observation periods, though cell line studies cannot establish therapeutic equivalence in living organisms. Phytochemical profiling studies have identified over 170–250 distinct metabolites in fireweed preparations, including myricetin derivatives, galloyl glucose esters, and multiple quercetin and kaempferol glycoforms, with organic cultivation and freeze-drying documented to preserve the highest polyphenol concentrations. The overall quality of evidence is preliminary, warranting significant caution in extrapolating in vitro findings to clinical recommendations, and the absence of standardized extraction protocols across studies limits inter-study comparability.
Preparation & Dosage
Traditional preparation
**Traditional Herbal Infusion (Tea)**
2–4 g) of dried fireweed leaves steeped in 200–250 mL of hot water (80–90°C) for 10–15 minutes; consumed 1–3 times daily in Scandinavian folk medicine for prostate and gastrointestinal complaints; standardization is absent from commercial teas
1–2 teaspoons (.
**Freeze-Dried Leaf Extract**
24 mg quercetin equivalents per gram have been used in in vitro studies; no commercial standardized extract with verified human dosing exists
Research preparations standardized to flavonoid content of 53.04 ± 1..
**Aqueous (Water-Based) Extract**
Preferred over ethanol extracts based on in vitro data demonstrating superior antiproliferative and antimicrobial activity; in vitro effective concentrations of 25–250 µg/mL are not directly translatable to oral doses.
**Fermented Leaf Preparation**
Traditional Scandinavian and Russian preparation involving fermentation of fresh leaves for 24–48 hours, which reduces total polyphenol content compared to unfermented preparations; used historically as a beverage (Ivan Chai in Russian tradition) with milder taste profile.
**Standardized Oenothein B Extract**
Oenothein B content of 2–4.5% in raw material is used as a quality marker in European herbal commerce, particularly for prostate-support products; specific standardized commercial dosing has not been validated in clinical trials.
**Timing Note**
No clinical pharmacokinetic data exist to guide timing relative to meals; post-digestion retention of bioactivity in in vitro simulated digestion models suggests that polyphenols survive gastric transit, but absorption and bioavailability in humans have not been quantified.
Nutritional Profile
Fireweed leaves are nutritionally significant as a whole food, particularly young shoots consumed as a vegetable, providing vitamins A and C, alongside calcium, potassium, and magnesium, though precise macronutrient data per standardized serving are not consistently reported in the phytochemical literature. The dominant phytochemical contribution comes from the polyphenol fraction: total polyphenols in dried organic leaves reach 4,189.80 mg/100 g dry matter, with ellagic acid the single largest identified compound at 2,790.44 mg/100 g DM, followed by p-coumaric acid at 208.41 mg/100 g DM and quercetin-3-O-rutinoside at 79.19 mg/100 g DM. Freeze-dried infusion powders contain flavonoids at 53.04 ± 1.24 mg quercetin equivalents per gram alongside phenolic acids including gallic, vanillic, hydroxybenzoic, ferulic, and chlorogenic acids, as well as galloyl glucose derivatives. Bioavailability of the ellagitannin fraction is subject to gut microbiome conversion of ellagic acid to urolithins, which are the primary absorbed metabolites; quercetin glucuronides demonstrate relatively higher intestinal stability compared to aglycone forms based on simulated digestion data, and over 170 metabolites have been identified across chromatographic profiling studies reflecting substantial chemical complexity.
How It Works
Mechanism of Action
Quercetin glucuronide and kaempferol-3-O-rhamnoside (afzelin), the dominant flavonoids in fireweed infusions at 593.0 µg/mL and 148.2 µg/mL respectively post-digestion, inhibit cancer cell proliferation by suppressing cyclin-dependent kinase activity and interfering with DNA replication machinery, with quercetin additionally acting as a competitive inhibitor of tyrosine kinases and a modulator of the PI3K/Akt/mTOR signaling cascade. Oenothein B, a macrocyclic ellagitannin present at 2–4.5% in raw plant material, is thought to contribute antiproliferative and anti-androgenic effects partly through inhibition of aromatase enzyme activity and modulation of 5-alpha-reductase, providing a mechanistic basis for prostate-related traditional indications. Chlorogenic and neochlorogenic acids inhibit lipid peroxidation and scavenge reactive oxygen species through direct electron donation, while also modulating the Nrf2/ARE antioxidant response pathway to upregulate endogenous antioxidant enzymes including superoxide dismutase and glutathione peroxidase. The ellagitannin fraction additionally exerts antimicrobial activity by disrupting bacterial cell membrane integrity and inhibiting bacterial DNA gyrase, selectively targeting gram-negative pathogens such as E. coli without adversely affecting gram-positive beneficial gut flora.
Clinical Evidence
No human clinical trials investigating fireweed supplementation for any indication have been reported in the available indexed literature, making it impossible to provide effect sizes, confidence intervals, or evidence-based dosing recommendations from controlled human research. The strongest mechanistic data derive from in vitro antiproliferative experiments using HT-29 colon cancer and astrocytoma cell lines, where aqueous extracts consistently outperformed ethanol extracts in efficacy, reducing cell proliferation to 27% of control at 250 µg/mL over 60 hours. Traditional ethnobotanical use in Scandinavian medicine for benign prostatic hyperplasia and gastrointestinal complaints has been documented historically but not quantitatively validated through prospective outcomes research. Confidence in clinical translation is very low; fireweed should be considered an ingredient of phytochemical interest requiring Phase I/II human safety and pharmacokinetic trials before therapeutic claims can be substantiated.
Safety & Interactions
Fireweed consumed as a traditional herbal tea at customary Scandinavian doses (1–3 cups daily of standard leaf infusions) has not been associated with reported adverse effects in the published literature, and in vitro cytotoxicity data indicate selective activity against cancer cell lines without measurable harm to beneficial gut bacterial populations at concentrations achievable through infusion. No formal human toxicology studies, maximum tolerated dose investigations, or structured adverse event monitoring have been conducted, making it impossible to define a safe upper intake limit with scientific precision. Potential drug interactions are mechanistically plausible but unverified: the high quercetin content raises theoretical concern for interactions with CYP3A4- and CYP2C8-metabolized drugs (including certain statins, immunosuppressants, and anticoagulants), and oenothein B's proposed aromatase-inhibiting activity suggests caution in individuals using hormone-sensitive medications or undergoing hormone therapy for prostate or breast cancer. Safety during pregnancy and lactation has not been evaluated in any published study, and use during these periods should be avoided on precautionary grounds; individuals with known hypersensitivity to Onagraceae family plants should exercise caution.
Synergy Stack
Hermetica Formulation Heuristic
Also Known As
Epilobium angustifoliumGreat WillowherbIvan ChaiRosebay WillowherbBombweed
Frequently Asked Questions
What is fireweed used for in traditional Scandinavian medicine?
In Scandinavian folk medicine, fireweed (Epilobium angustifolium) has been used primarily as a herbal infusion for benign prostatic hyperplasia and urinary tract complaints in older men, a use attributed to the ellagitannin oenothein B, which comprises 2–4.5% of the raw plant material and is thought to modulate aromatase and 5-alpha-reductase enzymes relevant to prostate tissue growth. It has also been used for gastrointestinal complaints including gastritis and diarrhea, leveraging the anti-inflammatory and mucosal-protective properties of its chlorogenic acid and quercetin glycoside content. No human clinical trials have confirmed these traditional indications, so they remain supported by ethnobotanical documentation and preclinical mechanistic data only.
Does fireweed have anticancer properties?
Fireweed extracts have demonstrated antiproliferative activity against human cancer cell lines in vitro, most notably reducing HT-29 colon adenocarcinoma proliferation to approximately 27% of control values at 250 µg/mL over 60 hours, and inhibiting DNA synthesis in astrocytoma cells, with aqueous extracts outperforming ethanol preparations. The responsible compounds are primarily quercetin glucuronide (593.0 µg/mL in post-digestion infusions), kaempferol glycosides, and oenothein B, which collectively modulate cell cycle kinases and oxidative stress pathways. These findings are entirely preclinical; no human clinical trials have been conducted, and in vitro results cannot be directly extrapolated to therapeutic anticancer effects in patients.
How much oenothein B does fireweed contain?
Oenothein B, the signature macrocyclic ellagitannin of Epilobium angustifolium, is present at concentrations ranging from approximately 2% to 4.5% of raw plant dry weight, with variation attributable to geographic origin of cultivation, harvest timing, and post-harvest processing methods. Organic and biodynamic growing conditions are associated with higher total ellagitannin yields, and freeze-drying has been shown to better preserve polyphenol content than conventional drying. Ellagic acid—the hydrolysis product of oenothein B and other ellagitannins—was quantified at 2,790.44 mg per 100 g dry matter in dried organic fireweed leaves, reflecting the overall richness of this ellagitannin fraction.
What is the recommended dose of fireweed tea or supplement?
No standardized supplemental dose for fireweed has been established through human clinical trials, as no such trials have been published. Traditional Scandinavian and Russian use involves infusions prepared from 2–4 g of dried leaves in 200–250 mL of hot water (80–90°C), consumed one to three times daily. In vitro studies have used extract concentrations of 25–250 µg/mL, but these cannot be directly converted to oral doses without pharmacokinetic data; consumers using commercial fireweed products should follow manufacturer guidance and consult a healthcare provider, particularly when using it alongside medications.
Is fireweed safe to take daily, and are there any drug interactions?
Fireweed consumed as a traditional herbal tea at customary doses has not been linked to reported adverse effects in published studies, and in vitro data indicate selective toxicity toward pathogenic bacteria without harming beneficial gut flora. However, no formal human safety studies exist, meaning an evidence-based upper safe limit cannot be defined. Theoretical drug interactions are plausible due to the high quercetin content, which may inhibit CYP3A4 and CYP2C8 enzymes involved in metabolizing statins, immunosuppressants, and anticoagulants, and the putative aromatase-inhibiting activity of oenothein B warrants caution in individuals on hormone therapy; use during pregnancy and lactation is not recommended due to a complete absence of safety data.
Does fireweed work better for prostate health as a tea, tincture, or capsule supplement?
Clinical research specifically examining delivery method efficacy for fireweed's prostate-supporting compounds is limited, though traditional Scandinavian use primarily employed hot water infusions (tea) to extract oenothein B and ellagitannins. Tinctures and standardized capsules may offer more concentrated doses and consistent bioavailability compared to brewed tea, but direct comparative studies in humans are lacking. The choice between forms should consider personal preference, convenience, and whether you prioritize traditional preparation methods or standardized dosing.
Is fireweed appropriate for men over 65 with existing prostate conditions?
Fireweed is generally considered safe for older adults and is traditionally used by men in Scandinavian countries as part of prostate wellness regimens. However, men with diagnosed benign prostatic hyperplasia (BPH) or prostate cancer should consult their healthcare provider before using fireweed, as its proposed effects on aromatase and 5-alpha-reductase activity could potentially interact with existing prostate treatments or conditions. Age alone is not a contraindication, but individual medical status and concurrent medications warrant professional guidance.
What does current research show about fireweed's effectiveness compared to other herbal prostate remedies like saw palmetto?
While saw palmetto has more robust clinical trial data in humans for benign prostatic hyperplasia, fireweed's oenothein B compound shows promise in laboratory and animal studies for modulating prostate-related enzymes, though human clinical verification remains pending. Direct head-to-head comparison studies between fireweed and saw palmetto or other prostate herbs are not yet published in peer-reviewed literature. The evidence base for fireweed is currently stronger in traditional use and preliminary biochemical research than in large-scale human trials.
Explore the Full Encyclopedia
7,400+ ingredients researched, verified, and formulated for optimal synergy.
Browse IngredientsThese statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.
hermetica-encyclopedia-canary-zzqv9k4w fireweed-epilobium-angustifolium curated by Hermetica Superfoods at ingredients.hermeticasuperfoods.com and licensed CC BY-NC-SA 4.0 (non-commercial share-alike, attribution required)
